Gilead Sciences, Inc. (Nasdaq: GILD) today announced new research to be presented at The Liver Meeting® 2024, hosted by the ...
Professor Ramou Njie made this disclosure recently during her presentation as part of activities marking liver cancer ...
The diagnosis of precore mutant chronic hepatitis B (CHB ... in this setting is to induce a sustained suppression of liver disease activity before cirrhosis or hepatocellular carcinoma (HCC ...
Gilead Sciences, Inc. (GILD), headquartered in Foster City, California, is a global biopharmaceutical leader known for its ...
Less than half of those who tested positive for HIV in Pretoria were aware of their HIV status. As such they would not have ...
Acute fatty liver of pregnancy (AFLP) is a rare obstetric complication, and despite improvements in recognition and management over recent decades, it still carries a high risk of maternal and fetal ...